# Pacira doubles EXPAREL manufacturing capacity with new suite in Swindon, UK

Pacira Pharmaceuticals announced that commercial production of EXPAREL has started at a custom suite in Swindon, UK, created with Thermo Fisher Scientific. The suite doubles manufacturing capacity, and a second suite is planned to double capacity again in about two years.

- Type: Expansion
- Announced: 2019-02-12
- Where: Swindon, UK, United Kingdom
- Starts operating: 12 Feb 2019
- Status: completed
- Capacity: doubles previous capacity
- Products: EXPAREL (bupivacaine liposome injectable suspension)

## Companies

- [Pacira Pharmaceuticals](https://endata.com/companies/37261.md)
- [Thermo Fisher Scientific](https://endata.com/companies/7061.md) (partner)

## Sources

- [globenewswire.com](https://www.globenewswire.com/news-release/2019/02/12/1720686/0/en/Pacira-Expands-EXPAREL-Manufacturing-Capacity-to-Meet-Growing-Demand.html), 2019-02-12: "This first suite was designed to mirror the company’s existing facility at the Pacira Science Center Campus in San Diego, CA and is expected to double the company’s manufacturing capacity."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.